Armistice Capital’s Radiopharm Theranostics RADX Stock Holding History
Bought
Maintained
Sold
Other funds holding RADX
Armistice Capital's RADX Position: Q3 2026 in Review
Armistice Capital opened a new position in Radiopharm Theranostics (RADX) in Q3 2026: 450,000 shares worth $729K. The stake represents 0.01% of the portfolio and ranks #187 among its holdings.
8 funds tracked by Wall St. Rank hold RADX as of Q3 2026.
- Armistice Capital held 450,000 shares of Radiopharm Theranostics worth $729K as of Q3 2026.
- Radiopharm Theranostics was a new Armistice Capital position in Q3 2026.
- Radiopharm Theranostics made up 0.01% of Armistice Capital's portfolio in Q3 2026, its #187 holding.
- 8 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.